D’Silva Brings Over 10 Years of Equity Research Experience ROCHESTER, Mich. , Sept. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp.  (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has appointed Andrew D’Silva to the

OptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category ROCHESTER, Mich. , Sept. 07, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it

ROCHESTER, Mich. , Sept. 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s CEO, will present at the upcoming Lake Street

The Companies’ combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction ROCHESTER, Mich. , Aug. 17, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp.  (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies,

- Revenue Up 55% to $13.6 million , closing on 19 enterprise contracts - Enterprise deals pipeline grows from 46 to 63 - Brands adopting OptimizeRx solutions increases to 140 from 80 in the past 6 months - Successful implementation of evidence-based provider engagement programs, driven by

ROCHESTER, Mich. , July 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, August 4, 2021, at 4:30 p.m.

OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans ROCHESTER, Mich. , July 14, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp.   (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life

Continued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunology ROCHESTER, Mich. , June 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies,

ROCHESTER, Mich. , June 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s CEO, will participate in the LD Micro Virtual

ROCHESTER, Mich. , May 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s, CEO will participate in a fireside chat at the